humulin-s and Long-QT-Syndrome

humulin-s has been researched along with Long-QT-Syndrome* in 1 studies

Trials

1 trial(s) available for humulin-s and Long-QT-Syndrome

ArticleYear
Sustained heart rate-corrected QT prolongation during recovery from hypoglycaemia in people with type 1 diabetes, independently of recovery to hyperglycaemia or euglycaemia.
    Diabetes, obesity & metabolism, 2023, Volume: 25, Issue:6

    To investigate changes in cardiac repolarization abnormalities (heart rate-corrected QT [QT. In a randomized crossover study, 24 individuals with type 1 diabetes underwent two experimental clamps with three steady-state phases during electrocardiographic monitoring: (1) a 45-minute euglycaemic phase (5-8 mmol/L), (2) a 60-minute insulin-induced hypoglycaemic phase (2.5 mmol/L), and (3) 60-minute recovery in either hyperglycaemia (20 mmol/L) or euglycaemia (5-8 mmol/L).. All measured markers of arrhythmic risk indicated increased risk during hypoglycaemia. These findings were accompanied by a decrease in vagal tone during both hyperglycaemia and euglycaemia clamps. Compared with baseline, the QT. In people with type 1 diabetes, insulin-induced hypoglycaemia prolongs cardiac repolarization, which is sustained during a 60-minute recovery period independently of recovery to hyperglycaemia or euglycaemia. Thus, vulnerability to serious cardiac arrhythmias and sudden cardiac death may extend beyond a hypoglycaemic event, regardless of hyperglycaemic or euglycaemic recovery.

    Topics: Arrhythmias, Cardiac; Cross-Over Studies; Diabetes Mellitus, Type 1; Heart Rate; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin, Regular, Human; Long QT Syndrome

2023